Related Experiment Video
Updated: Jul 9, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
The glucocorticoid receptor signalling in breast cancer
Paraskevi Moutsatsou1, Athanasios G Papavassiliou
1Department of Biological Chemistry, Medical School, University of Athens, Athens, Greece. pmoutsatsou@med.uoa.gr
Abstract:
Glucocorticoids are provided as co-medication with chemotherapy in breast cancer, albeit several lines of evidence indicate that their use may have diverse effects and in fact may inhibit chemosensitivity. The molecular basis of glucocorticoid-induced resistance to chemotherapy in breast cancer remains poorly defined. Recent researchers, in an attempt to clarify some aspects of the underlying pathways, provide convincing evidence that glucocorticoids induce effects that are dependent upon the glucocorticoid receptor -mediated transcriptional regulation of specific genes known to play key roles in cellular/tissue functions, including growth, apoptosis, differentiation, metastasis and cell survival. In this review, we focus on how glucocorticoid-induced chemoresistance in breast cancer is mediated by the glucocorticoid receptor, unraveling the molecular interplay of glucocorticoid receptor signaling with other signaling cascades prevalent in breast cancer. We also include a detailed description of glucocorticoid receptor structure and function, summarizing data gained during recent years into the mechanism(s) of the cross-talk between the glucocorticoid receptor and other signaling cascades and secondary messengers, via which glucocorticoids exert their pleiotropic effects.
Insights
Glucocorticoids, used with chemotherapy for breast cancer, can reduce treatment effectiveness by activating the glucocorticoid receptor. This receptor influences genes controlling cell growth, survival, and metastasis, leading to chemoresistance.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Glucocorticoids are commonly co-administered with chemotherapy for breast cancer.
- Evidence suggests glucocorticoids may paradoxically inhibit chemotherapy effectiveness (chemosensitivity).
- The molecular mechanisms underlying glucocorticoid-induced chemoresistance in breast cancer are not fully understood.
Purpose of the Study:
- To review the molecular basis of glucocorticoid-induced chemoresistance in breast cancer.
- To elucidate the role of the glucocorticoid receptor in mediating these effects.
- To explore the interplay between glucocorticoid receptor signaling and other relevant signaling pathways in breast cancer.
Main Methods:
- Review of existing literature on glucocorticoid action in breast cancer.
- Analysis of glucocorticoid receptor-mediated transcriptional regulation.
- Examination of signaling cascade cross-talk in breast cancer.
Main Results:
- Glucocorticoids induce effects via glucocorticoid receptor-mediated transcriptional regulation.
- This regulation impacts genes involved in cell growth, apoptosis, differentiation, metastasis, and survival.
- Glucocorticoid receptor signaling interacts with other prevalent signaling cascades in breast cancer.
Conclusions:
- Glucocorticoid receptor signaling is a key mediator of chemoresistance in breast cancer.
- Understanding the molecular interplay of glucocorticoid receptor with other pathways is crucial.
- Further research into these mechanisms may reveal strategies to overcome glucocorticoid-induced chemoresistance.
Related Concept Videos
Cell Signaling in Plants
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Insulin: The Receptor and Signaling Pathways
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

